US EditionVeracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
Summary by Eagle-Tribune
3 Articles
3 Articles
All
Left
Center
1
Right
Veracyte Expands Decipher Prostate Test For Metastatic Patients
The Decipher Prostate test, already widely used for patients with localized disease, is now the only gene expression test available and covered by Medicare to inform treatment decisions for patients across the full continuum of prostate cancer risk.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
